Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

"From my phone, I could rule the world": Critical engagement with maternal vaccine information, vaccine confidence builders and post-Zika outbreak rumours in Brazil.
Simas, C; PATERSON, P; LEES, S; J Larson, H;
2021
Vaccine, (2021).39 33 10.1016/j.vaccine.2021.06.039.
A Dose Reduction Immunobridging and Safety Study of two HPV vaccines in Tanzanian girls: serology & immunobridging.
WATSON-JONES, D;
2021
(2021).
Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review.
SAADI, N; Chi, Y-L; Ghosh, S; EGGO, RM; MCCARTHY, C; QUAIFE, M; Dawa, J; JIT, M; VASSALL, A;
2021
medRxiv (2021). 10.1101/2021.06.21.21259104.
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
Patel, MK; Bergeri, I; Bresee, JS; Cowling, BJ; Crowcroft, NS; Fahmy, K; Hirve, S; Kang, G; Katz, MA; Lanata, CF; L'Azou Jackson, M; Joshi, S; Lipsitch, M; Mwenda, JM; Nogareda, F; Orenstein, WA; Ortiz, JR; Pebody, R; Schrag, SJ; SMITH, PG; Srikantiah, P; Subissi, L; Valenciano, M; Vaughn, DW; Verani, JR; ... Feikin, DR.
2021
Vaccine, (2021).39 30 10.1016/j.vaccine.2021.05.099.
Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis.
SANDMANN, F; JIT, M; Andrews, N; Buckley, HL; Campbell, H; Ribeiro, S; Sile, B; Stowe, J; Tessier, E; Ramsay, M; Amirthalingam, G; Choi, YH;
2021
Vaccine, (2021).39 32 10.1016/j.vaccine.2021.06.042.
Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine.
Dassah, S; Adu, B; Sirima, SB; Mordmüller, B; Ngoa, UA; Atuguba, F; Arthur, FK N; Mensah, BA; Kaddumukasa, M; Bang, P; Kremsner, PG; Mategula, D; Flach, C; MILLIGAN, P; Theisen, M;
2021
Vaccine, (2021).39 31 10.1016/j.vaccine.2021.06.024.
Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
Gaythorpe, KA; ABBAS, K; Huber, J; Karachaliou, A; Thakkar, N; Woodruff, K; Li, X; Echeverria-Londono, S; VIMC Working Group on COVID-19 Impact on Vaccine P,; Ferrari, M; Jackson, ML; McCarthy, K; Perkins, TA; Trotter, C; JIT, M;
2021
eLife, (2021).10, 10.7554/eLife.67023.
Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens.
DEOL, AK; SCARPONI, D; Beckwith, P; Yates, TA; Karat, AS; Yan, AW C; BAISLEY, KS; GRANT, AD; WHITE, RG; MCCREESH, N;
2021
PloS one, (2021).16 6 10.1371/journal.pone.0253096.
SARS-CoV-2 Variants and Vaccines.
Krause, PR; Fleming, TR; Longini, IM; Peto, R; Briand, S; HEYMANN, DL; Beral, V; Snape, MD; Rees, H; Ropero, A-M; Balicer, RD; Cramer, JP; Muñoz-Fontela, C; Gruber, M; Gaspar, R; Singh, JA; Subbarao, K; Van Kerkhove, MD; Swaminathan, S; Ryan, MJ; Henao-Restrepo, A-M;
2021
New England Journal of Medicine, (2021).385 2 10.1056/NEJMsr2105280.
Optimising health and economic impacts of COVID-19 vaccine rollout strategies in the WHO European Region.
LIU, Y; Sandmann, FG; BARNARD, RC; PEARSON, CA B; CMMID Working-19 Working Group,; Pastore, R; Pebody, R; FLASCHE, S; JIT, M;
2021
, Zenodo (2021).